Akanda (AKAN) Total Current Liabilities (2020 - 2025)
Akanda (AKAN) recorded quarterly Total Current Liabilities of $2.8 million in Q2 2025, down 21.84% quarter-over-quarter from $3.6 million in Q4 2024, and down 47.31% on a YoY basis from $5.4 million in Q2 2024.
Akanda (AKAN) Total Current Liabilities (2020 - 2025) Analysis & Trends
Akanda's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $2.8 million for Q2 2025.
- In Q2 2025, Total Current Liabilities fell 47.31% year-over-year to $2.8 million; the TTM figure through Jun 2025 stood at $2.8 million (down 47.31% YoY), while the FY2024 annual figure was $3.6 million, down 64.24% from the prior year.
- Total Current Liabilities was $2.8 million for Q2 2025 at Akanda, down from $3.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $12.4 million in Q2 2023 to a low of $2.8 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $7.3 million across 5 years, with a median of $7.3 million in 2021.
- The sharpest annual moves came in 2021 and 2024: Total Current Liabilities jumped 202.71% in 2021, then sank 64.24% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $8.3 million in 2021, then climbed by 13.05% to $9.3 million in 2022, then grew by 8.81% to $10.2 million in 2023, then tumbled by 64.24% to $3.6 million in 2024, then dropped by 21.84% to $2.8 million in 2025.
- The last three Total Current Liabilities figures came in at $2.8 million (Q2 2025), $3.6 million (Q4 2024), and $5.4 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Akanda | 826.99 Mn | 824.46 Mn | - | 6.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.20 Mn |
| Jun 30, 2025 | 2.84 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Dec 31, 2023 | 10.17 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Jun 30, 2022 | 6.27 Mn |
| Dec 31, 2021 | 8.27 Mn |
| Dec 31, 2020 | 2.73 Mn |